Medable

Meet Us at SCOPE Summit 2026


Be part of the future of clinical trials. At SCOPE Summit 2026, Medable is offering exclusive 1:1 meetings with our team of experts to explore how our award-winning digital platform can revolutionize your clinical operations.


Why you don't want to miss SCOPE 2026
Meet with us in Orlando to see how leading teams are using AI to transform clinical development.


  • Explore Agent Studio, Medable’s AI agent platform purpose-built for clinical development
  • See how to reduce rework loops, accelerate eCOA study builds, and unlock real-time insights from portfolio to patient
  • Get a tailored, confidential assessment of how Medable can support your specific business needs

Act now. Capacity is limited.
Last year, most meeting slots were booked weeks before the conference. Secure yours early to ensure dedicated time with our team.

  • Rosen Shingle Creek, 9939 Universal Blvd, Orlando, FL 32819
  • February 2 - February 5

Book a meeting

Schedule a meeting or demo with our platform experts at our DIA booth.

Book a 30 minute meeting

Schedule a brief introductory conversation at SCOPE Summit 2026 with our trial and technology experts.

Meet the Medable team

Schedule a meeting to talk with one of our clinical research and trial experts.
Chief Executive Officer
Michelle Longmire
Discuss your DCT and enterprise solutions for pharma and biotech.
Chief Revenue Officer
Jason Rothbart
Discuss your DCT and enterprise solutions for pharma and biotech.
Executive General Manager, Customer Value
Andrew Mackinnon
Discuss the ROI of Medable Studio, eConsent, and site adoption.
Chief Scientific Officer
Pamela Tenaerts
Discuss the ROI of Medable Studio, eConsent, and site adoption.
Chief Customer Officer
Alison Holland
Discuss eCOA strategy, current FDA Guidelines, and how to best plan for using eCOA in your trial.
Chief Revenue Officer
Dave Orrico
Discuss your DCT and enterprise solutions for pharma and biotech.
SVP of Global Enterprise Sales
Dave Orrico
Discuss your DCT and enterprise solutions for pharma and biotech.
Solution Consultant
Rj Lozano
Meet to receive a product demo for Total Consent, eCOA+ and more.

How Medable is making the Design, Configuration and Launch of Studies Easier, More Efficient and With Better Outcomes


Track: C9: Decentralized & Hybrid

Abstract:
Medable Studio is a fully featured SaaS suite of study design, configuration, translation and launch tools that enables easy and efficient study builds. In this presentation Medable, with a partner from a key customer, will talk about design best practice, how Studio has enabled faster study launch, and the adherence and satisfaction outcomes that have been observed in live studies.
  • TBD
  • Wednesday, February 5
  • 9:55 AM EST
  • 30 minutes
FEB

5

Andrew Mackinnon
MEDABLE
Executive General Manager, Customer Value

Angela DeLuca
TAKEDA
Vice President, Head of Oncology & Cell Therapies Clinical Operations, Global Development Office, R&D

Michael Greeley
Flare Capital Partners
Co-Founder & General Partner, Healthcare Technology

Achieving Flexibility and Expanding Access While Preserving Data Quality

Track: C9 DCTs & Clinical Innovation

Moderator:
Lindsay Kehoe, Project Manager, Clinical Trials Transformation Initiative

Panelists:
Pamela Tenaerts, CSO, Medable
Wes Burian, Patient
Charmaine Demanuele, PhD, Executive Director, Head, Quantitative Sciences for Digital Sciences & Translational Imaging, Pfizer Inc.
  • TBD
  • Thursday, February 6
  • 12:25 PM EST
  • 30 minutes
FEB

6

Pamela Tenaerts
MEDABLE
Chief Scientific Officer
Pamela Tenaerts
MEDABLE
Chief Scientific Officer
Special Guest
TBA
TBA

SESSION HIGHLIGHT

Responsibility and Oversight in Decentralized Clinical Trials

Join Medable’s CSO, Pamela Tenaerts to discuss issues that drive principal investigator (PI) oversight and responsibility in modern clinical trials where research and data gathering activities are no longer confined to the traditional site model.
Wed, June 28 | 10:30-11:30am

ROUNDTABLE DISCUSSION

RWD: Maximizing Value and Quality through End-to-End Patient Centricity

Join Medable’s VP, Digital Transformation Strategy, Reem Yunis and Walgreen’s Head, Digital Optimization, RWE Clinical Trials, Kendal Whitlock for a follow up roundtable discussion tied to session: Real-World Data: Maximizing Value and Quality through End-to-End Patient Centricity.
Wed, June 28 | 1:15-2:15pm
You’re on the list.
Somebody will reach out to you soon to schedule a sneak peek of our upcoming product features and capabilities. In the meantime, enjoy our latest content about the future of clinical trials.
EXPLORE CONTENT

You’re invited! Join Medable at our After Party (RSVP Only).

RSVP here
Unified clinical trials.
  • Privacy Policy
  • Legal
  • © 2023 Medable Inc. All rights Reserved